blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0807624

EP0807624 - RETINOIC ACID DERIVATIVES [Right-click to bookmark this link]
Former [1997/47]Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
[2005/52]
StatusPatent revoked
Status updated on  19.03.2010
Database last updated on 05.10.2024
Most recent event   Tooltip10.06.2011Lapse of the patent in a contracting state
New state(s): IT
published on 13.07.2011  [2011/28]
Applicant(s)For all designated states
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 North Torrey Pines Road La Jolla
California 92037 / US
For all designated states
BAYLOR COLLEGE OF MEDICINE
One Baylor Plaza
Houston, TX 77030 / US
For all designated states
LIGAND PHARMACEUTICALS, INC.
9393 Towne Centre Drive, Suite 100
San Diego, CA 92121 / US
[2009/33]
Former [1997/47]For all designated states
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
10010 North Torrey Pines Road
La Jolla California 92037 / US
For all designated states
BAYLOR COLLEGE OF MEDICINE
One Baylor Plaza
Houston, TX 77030 / US
For all designated states
LIGAND PHARMACEUTICALS, INC.
9393 Town Centre Drive, Suite 100
San Diego, CA 92121 / US
Inventor(s)01 / Evans, Roland M.
8615 La Jolla Scenic Road
La Jolla, CA 92037 / US
02 / Mangelsdorf, David J.
4771 Seaford Place
San Diego, CA 92117 / US
03 / Heyman, Richard A.
147 Honeycomb Court
Encinitas, CA 92024 / US
04 / Boehm, Marcus F.
4007 Everts Street, 4J
San Diego, CA 92109 / US
05 / Eichele, Gregor
2030 Swift Boulevard
Houston, TX 77030 / US
06 / Thaller, Christina
2030 Swift Boulevard
Houston, TX 77030 / US
[1997/47]
Representative(s)Polz, Leo, et al
Hoffmann - Eitle
ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR / DE
[N/P]
Former [2003/37]Polz, Leo, Dr., et al
Hoffmann Eitle Postfach 81 04 20
81904 München / DE
Former [1997/47]Kolb, Helga, Dr. Dipl.-Chem., et al
Hoffmann Eitle, Patent- und Rechtsanwälte, Arabellastrasse 4
81925 München / DE
Application number, filing date97105922.518.12.1992
[1997/47]
Priority number, dateUS1991080998018.12.1991         Original published format: US 809980
[1997/47]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0807624
Date:19.11.1997
Language:EN
[1997/47]
Type: A3 Search report 
No.:EP0807624
Date:29.09.1999
[1999/39]
Type: B1 Patent specification 
No.:EP0807624
Date:12.08.2009
Language:EN
[2009/33]
Search report(s)(Supplementary) European search report - dispatched on:EP12.08.1999
ClassificationIPC:C07C403/20, A61K31/07
[1997/47]
CPC:
C12P7/64 (EP); A61K31/07 (EP); A61K31/19 (EP);
A61K31/20 (EP); A61K31/203 (EP); A61K31/23 (EP);
A61K31/232 (EP); A61P17/00 (EP); A61P3/06 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
C07C403/20 (EP); C07C57/26 (EP); C07C59/46 (EP);
C07C59/80 (EP); C07K14/70567 (EP); C12P7/04 (EP);
C12P7/6409 (EP); C12P7/6436 (EP,US); C07C2601/16 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/47]
TitleGerman:RETINSÄUREDERIVATE[2005/52]
English:RETINOIC ACID DERIVATIVES[2005/52]
French:DÉRIVÉ D'ACIDE RETINOIQUE[2005/52]
Former [1997/47]Mitteln zur Modulierung von Verfahren durch Retinoid Rezeptoren und dafür nützliche Verbindungen
Former [1997/47]Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Former [1997/47]Procédés permettant la modulation de processus utilisant des récepteurs de rétinoides comme médiateurs et composés utiles dans ce contexte
Examination procedure10.04.1997Examination requested  [1997/47]
07.05.2002Despatch of a communication from the examining division (Time limit: M06)
04.11.2002Reply to a communication from the examining division
16.07.2003Despatch of a communication from the examining division (Time limit: M04)
26.11.2003Reply to a communication from the examining division
04.10.2004Despatch of a communication from the examining division (Time limit: M02)
14.12.2004Reply to a communication from the examining division
05.05.2006Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
27.11.2006Despatch of a communication from the examining division (Time limit: M04)
27.03.2007Reply to a communication from the examining division
05.11.2008Cancellation of oral proceeding that was planned for 06.11.2008
05.11.2008Minutes of oral proceedings despatched
06.11.2008Date of oral proceedings
06.11.2008Date of oral proceedings (cancelled)
28.01.2009Communication of intention to grant the patent
08.06.2009Fee for grant paid
08.06.2009Fee for publishing/printing paid
Parent application(s)   TooltipEP93902758.7  / EP0617614
Opposition(s)Opponent(s)01  14.08.2009  03.11.2009  ADMISSIBLE
Basilea Pharmaceutica AG
Grenzacherstrasse 487
4005 Basel / CH
Opponent's representative
Bohest AG, et al, et al
Postfach 160
4003 Basel / CH
 [N/P]
Former [2009/39]
Opponent(s)01  14.08.2009   
Basilea Pharmaceutica AG
Grenzacherstrasse 487
4005 Basel / CH
Opponent's representative
Bohest AG, et al, et al
Postfach 160
CH-4003 Basel / CH
01.12.2009Despatch of communication that the patent will be revoked
11.12.2009Legal effect of revocation of patent [2010/16]
Request for further processing for:06.06.2006Request for further processing filed
06.06.2006Full payment received (date of receipt of payment)
Request granted
27.06.2006Decision despatched
Fees paidRenewal fee
11.08.1997Renewal fee patent year 03
11.08.1997Renewal fee patent year 04
11.08.1997Renewal fee patent year 05
12.12.1997Renewal fee patent year 06
11.12.1998Renewal fee patent year 07
20.12.1999Renewal fee patent year 08
07.12.2000Renewal fee patent year 09
31.12.2001Renewal fee patent year 10
28.11.2002Renewal fee patent year 11
12.12.2003Renewal fee patent year 12
14.12.2004Renewal fee patent year 13
15.12.2005Renewal fee patent year 14
13.12.2006Renewal fee patent year 15
12.12.2007Renewal fee patent year 16
15.12.2008Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.08.2009
BE12.08.2009
CH12.08.2009
DK12.08.2009
IT12.08.2009
LI12.08.2009
NL12.08.2009
SE12.08.2009
ES23.11.2009
[2011/28]
Former [2010/28]AT12.08.2009
BE12.08.2009
CH12.08.2009
DK12.08.2009
LI12.08.2009
NL12.08.2009
SE12.08.2009
ES23.11.2009
Former [2010/19]AT12.08.2009
NL12.08.2009
SE12.08.2009
ES23.11.2009
Documents cited:Search[X]EP0237986  (SHUDO KOICHI [JP], et al);
 [X]WO8900157  (MOLECULAR DESIGN INT [US]);
 [X]FR2619309  (OREAL [FR]);
 [X]EP0371264  (UNIV LOYOLA CHICAGO [US]);
 [X]EP0376821  (OREAL [FR]);
 [X]ES2022025  (UNIV VALENCIA ESTUDI GENERAL [ES])
by applicantFR2619309
 EP0376821
 EP0552624
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.